ICON Schedules Q4 and Full Year 2025 Earnings Call Discloses Nasdaq Deficiency Notice Evercore ISI Lowers Price Target on Illinois Tool Works ITW Amid Revised Outlook Oil Prices Surge as US Military Strikes in Iran Raise Geopolitical Tensions Navigating the Gap Between Pay Raises and Inflation US Secretary of State Rubio Meets Indias Modi to Strengthen Energy Ties Amid Iran Supply Disruptions Market Rally Highlights Portfolio Winners and Laggards Over Recent Six Weeks DRD Q3 2014 Earnings NarrowerThanExpected Loss as Gold Producer Cuts Costs Cavco Industries Q1 2026 Earnings EPS Beats Estimates by 102 Stock Rises 36 BancFirst Corporation Q1 2026 Earnings EPS Beats Estimates Shares Edge Higher FCNCO Q1 2026 Earnings Preferred Dividend Coverage Strengthens with EPS Surprise IPSC Q1 2026 Earnings EPS Beats Estimates Stock Declines Slightly as Pipeline Advances WD Q1 2026 Earnings Strong EPS Beat Amid Quiet Revenue Period Singularity Future Technology SGLY Edges Higher Small Cap Stock Held in Tight Range Compass Minerals CMP Rises 1 as Shares Approach Resistance Near 3343 Melco Resorts MLCO Edges Lower Amid Sector Volatility Support Levels in Focus FTC Solar FTCI Edges Higher Amid Consolidation Near Support Datacentrex Inc DTCX Tests Support as Bearish Pressure Persists ROG Q1 2026 Earnings EPS Surpasses Estimates by 10 Stock Slightly Declines PermRock Royalty Trust PRT Q2 2023 Earnings Modest EPS Amid Quiet Quarter Stock Slips 36 Iveda Solutions Q2 2024 Earnings Loss Narrows More Than Expected Revenue Remains Undisclosed CorVel Q4 2026 Earnings Call Transcript Released Management Discusses Quarterly Performance and Strategic Direction FCBC Q1 2026 Earnings Modest EPS Miss Amid Stable Performance ICON Q4 2025 Earnings WiderthanExpected Loss Amid Challenging Operational Environment Europe Faces Strategic Vulnerability as US Dominance in Satellites and AI Grows Telecom CEO Warns Vista Gold Corp Q1 2026 Earnings EPS Loss of 002 as PreRevenue Producer Advances Mt Todd Lineage Cell Therapeutics LCTX Holds Near Support as Biotech Sector Headwinds Persist